KUALA LUMPUR, Nov 14 (Bernama) -- Dark Horse Consulting Group (DHC), a global consultancy to the cell and gene therapy (CGT) industry, has established an official foothold in the Asia Pacific (APAC) region, an area representing more than one third of CGT globally, by bringing on industry veteran John Ng as General Manager of its new APAC office.
“As Dark Horse Consulting continues to expand, a natural next step was to ensure that we had local expertise and support for our clients in the APAC region, which is the fastest-growing part of the world for CGT.
“John’s extensive experience and impressive track record fits well with our model of accelerating progress for our clients by providing deep and differentiated CGT expertise,” said DHC Founder and Chief Executive Officer, Anthony Davies in a statement.
Meanwhile, Ng said: “As a former client myself, I am excited for this opportunity to extend DHC’s exceptional services to a broader group of APAC clients. I look forward to growing DHC's presence in APAC to better serve this important and growing region for the CGT industry.”
Most recently, Ng served as Chief Technical Officer (CTO) of Tessa Therapeutics, a Singapore-based clinical-stage biotechnology company that was developing a portfolio of autologous and allogeneic cell therapy assets, and it grew from 30 employees to more than 200 during his seven-year tenure.
As CTO, Ng was responsible for the Operations organisation, which includes Manufacturing, Process Development, Quality, Programme Management, Engineering, and Global Supply Chain.
Before Tessa Therapeutics, he served in various leadership roles in Technical Operations in publicly listed companies, and also spent 10 years in China, responsible for Procurement, Global Supply Chain, and Programme Management.
Ng, a native Singaporean, holds a Bachelor of Engineering from the National University of Singapore, and is fluent in both English and Mandarin Chinese.
-- BERNAMA
No comments:
Post a Comment